These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 2114307

  • 1. The pathogenicity of Mycobacterium tuberculosis during chemotherapy.
    Clancy LJ, Kelly P, O'Reilly L, Byrne C, Costello E.
    Eur Respir J; 1990 Apr; 3(4):399-402. PubMed ID: 2114307
    [Abstract] [Full Text] [Related]

  • 2. [Place of bacteriological examination in the treatment of tuberculosis].
    Gyselen A.
    Acta Tuberc Pneumol Belg; 1972 Apr; 63(4):405-8. PubMed ID: 4206438
    [No Abstract] [Full Text] [Related]

  • 3. Liposome-based antitubercular drug therapy in a guinea pig model of tuberculosis.
    Pandey R, Sharma S, Khuller GK.
    Int J Antimicrob Agents; 2004 Apr; 23(4):414-5. PubMed ID: 15081096
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Double antibacterial therapy in untreated tuberculosis. Retrospective study of 120 unselected patients treated between 1972 and 1974].
    Augé C, Lecocguic Y, Touaty E, Bussi S, Pariente R.
    Rev Fr Mal Respir; 1982 Apr; 10(6):391-9. PubMed ID: 6819611
    [No Abstract] [Full Text] [Related]

  • 6. Bacteriologic basis of short-course chemotherapy for tuberculosis.
    Grosset J.
    Clin Chest Med; 1980 May; 1(2):231-41. PubMed ID: 6794976
    [No Abstract] [Full Text] [Related]

  • 7. Tuberculosis in Acukland.
    Swinburn PD.
    N Z Med J; 1973 Dec 26; 78(505):520-5. PubMed ID: 4205888
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A case of skin and lung tuberculosis: diagnostic difficulties.
    Colasanti P, Cardone M, Zanchini R, Cordedda M, Grande A, Mozzillo R.
    G Ital Dermatol Venereol; 2013 Oct 26; 148(5):538-40. PubMed ID: 24005149
    [No Abstract] [Full Text] [Related]

  • 10. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R, Borgdorff MW, Sticht-Groh V, Rieder HL, Kawuma HJ, Bretzel G, Rüsch-Gerdes S.
    East Afr Med J; 1999 Jun 26; 76(6):307-13. PubMed ID: 10750516
    [Abstract] [Full Text] [Related]

  • 11. Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis.
    Wang JY, Lee LN, Yu CJ, Chien YJ, Yang PC, Tami Group.
    Respirology; 2009 Sep 26; 14(7):1012-9. PubMed ID: 19659516
    [Abstract] [Full Text] [Related]

  • 12. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM, Goldberg SV.
    Int J Tuberc Lung Dis; 2002 Nov 26; 6(11):952-8. PubMed ID: 12475140
    [Abstract] [Full Text] [Related]

  • 13. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK, Kim JH, Kang H, Cho JS, Smego RA.
    Int J Infect Dis; 2009 Mar 26; 13(2):170-5. PubMed ID: 18768342
    [Abstract] [Full Text] [Related]

  • 14. [The infectiousness of tuberculosis].
    Dierkesmann R.
    Offentl Gesundheitswes; 1990 Mar 26; 52(8-9):501-5. PubMed ID: 2146566
    [Abstract] [Full Text] [Related]

  • 15. [Principles of rational tuberculosis chemotherapy].
    Khomenko AG.
    Antibiotiki; 1980 Jul 26; 25(7):534-9. PubMed ID: 7406466
    [Abstract] [Full Text] [Related]

  • 16. [The nature of bacterial secretions in patients with focal pulmonary tuberculosis].
    Il'ina TIa.
    Probl Tuberk; 1974 Jul 26; (10):6-10. PubMed ID: 4213567
    [No Abstract] [Full Text] [Related]

  • 17. [Cooperative study of short-term antibacillary treatments in 14 French centers].
    Brouet G.
    Bull Int Union Tuberc; 1974 Jul 26; 49(1):398-410. PubMed ID: 4219734
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of the effectiveness of 2 treatment regimens in patients with isoniazid-resistant tuberculosis.
    Tabarsi P, Baghaei P, Hemmati N, Mirsaeidi M, Kazempour M, Mansouri D, Masjedi MR.
    East Mediterr Health J; 2009 Jul 26; 15(6):1346-50. PubMed ID: 20218123
    [Abstract] [Full Text] [Related]

  • 19. Short-course treatment regimens for patients with tuberculosis.
    Dutt AK, Stead WW.
    Arch Intern Med; 1980 Jun 26; 140(6):827-9. PubMed ID: 6770770
    [No Abstract] [Full Text] [Related]

  • 20. [Question of bactericidal effect of a combination of maximally tolerable doses of INH, Myambutol and Rifadin on experimental tuberculosis].
    Djurisić M, Davidović C, Leposavić M, Jovancvić M, Marković L, Popović S.
    Plucne Bolesti Tuberk; 1973 Jun 26; 25(3):251-6. PubMed ID: 4210992
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.